کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
8730836 1590369 2018 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Tratamiento actual de la enfermedad por hígado graso no alcohólico
ترجمه فارسی عنوان
درمان فعلی این بیماری با الکل چربی غیر الکلی.
کلمات کلیدی
بیماری کبدی چربی غیر الکلی، سندرم متابولیک، درمان، بیماری کبدی چربی غیر الکلی، سندرم متابولیک، درمان،
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی بیماری‌های گوارشی
چکیده انگلیسی
Non-alcoholic fatty liver disease is the most prevalent hepatopathy, estimated at 30% in the general population. In the coming years, it will likely be the most common indication for liver transplantation and the most frequent cause of hepatocellular carcinoma. Current treatment for non-alcoholic fatty liver disease is based on dietary and exercise interventions that have been shown to be efficacious, even for reverting fibrosis. Unfortunately, compliance with general measures involving lifestyle modifications is very poor, making pharmacologic strategies a necessary option. At present, there are no treatments for non-alcoholic fatty liver disease approved by regulatory agencies, and the only ones with sufficient evidence and recommended by international societies are treatments with pioglitazone and vitamin E, which are not exempt from adverse effects. We review herein the current management of non-alcoholic fatty liver disease, including dietary and physical activity interventions, available treatments, equivocal therapies, emerging treatments, and treatments presently in clinical trials.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Revista de Gastroenterología de México - Volume 83, Issue 2, April–June 2018, Pages 125-133
نویسندگان
,